Healthcare/Biotech
Trust managing Lilavati Hospital says Rs 1,500crore misappropriated by ex-trustees; FIRs filed
The Lilavati Kirtilal Mehta Medical Trust alleged misappropriation of funds amounting to over Rs 1,500 crore by former trustees, impacting hospital services. Complaints were lodged, leading to FIRs. Forensic audits revealed manipulation and fund siphoning, and bizarrely, black magic rituals were also discovered on-site.
- India, vaccine superpower; manufactures 60% of global supply: ICMR former chief
- Zydus eyes major stake in French medtech Amplitude for Rs 2,446 crore
- ET Q&A: All our products are legitimate, sold under valid prescriptions, says Aveo Pharmaceuticals MD
- India's Syngene International acquires first US biologics facility for $36.5 million
- Govt invites proposals for funding under PRIP scheme
- Indian pharma cos to launch cheaper diabetes medicine at 90% lower price soon
- Zydus Lifesciences gets USFDA nod to market generic antifungal shampoo
- Sun Pharmaceuticals to acquire Checkpoint Therapeutics for $355 mn
- New drug export rule a bitter pill for sector: Pharma body
- Keep tobacco and alcohol ads and their proxies off IPL, Health ministry tells cricket board
- USFDA pulls up Granules India for lapses in maintaining storage facilities, equipment at Telangana plant
- Protecting your heart and managing diabetes: The power of a holistic lifestyle
Keep tobacco and alcohol ads and their proxies off IPL, Health ministry tells cricket board
USFDA pulls up Granules India for lapses in maintaining storage facilities, equipment at Telangana plant
Protecting your heart and managing diabetes: The power of a holistic lifestyle
Indian Pharmaceutical Alliance calls for zero import duty on US drugs to boost local industry
Registration for Ayushman Bharat to start after March 8: Delhi health minister
Surge in fake medicines in retail markets leaving druggists distraught: Traders' body
Biotech
India's Syngene International acquires first US biologics facility for $36.5 million- States to set up centres for effective implementation of BioE3 policy: Jitendra Singh
- Competition Commission of India penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal
- India's first Robotic-assisted Paediatric Gait Trainer for physical rehabilitation launched
- US co Intuitive Surgical bets on India growth & talent: CEO Gary S Guthart
Healthcare
Trust managing Lilavati Hospital says Rs 1,500crore misappropriated by ex-trustees; FIRs filed- Zydus eyes major stake in French medtech Amplitude for Rs 2,446 crore
- Keep tobacco and alcohol ads and their proxies off IPL, Health ministry tells cricket board
- Protecting your heart and managing diabetes: The power of a holistic lifestyle
- Registration for Ayushman Bharat to start after March 8: Delhi health minister
Pharmaceuticals
Must Watch
BACK TO TOP